Page 61 - journal_12-2_Full

165

States Pharmacopeia 32/The National Formulary 27.
‡μ√’¬¡‰¥â∑ÿ° Ÿμ√ºà“π‡°≥±å¡“μ√∞“π‡¿ —™μ”√—∫
Maryland: United Book Press; 2009. p. 262, 725-6.
¢Õß À√—∞Õ‡¡√‘°“·≈–‡¿ —™μ”√—∫¢ÕßÕ—ß°ƒ…
9. The United States Pharmacopeial Convention. The United
States Pharmacopeia 33/The National Formulary 28.
¢âÕ®”°—¥¢Õß°“√«‘®—¬ Maryland:United Book Press; 2010. p. R88.
10. The British Pharmacopoeia Commission. British
°“√»÷°…“π’Ȭ—߉¡à‰¥âª√–‡¡‘π§ÿ≥¿“æ¢Õß«—μ∂ÿ¥‘∫ Pharmacopoeia 2009. United Kingdom:Stationery Office;
2009. p. A291, 313, 441-3.
¡ÿπ‰æ√∑’Ë„™â
11. Shale SB, Ayane AT, Wabe NT. Comparative quality
evaluation of paracetamol tablet marketed in Somali region
°‘μμ‘°√√¡ª√–°“» of Ethiopia. Int J Pharm Sci Res. 2012;3(2):545-50.
12. Katori N, Aoyagi N, Kojima S. The study of the applicability
§≥–ºŸâ«‘®—¬¢Õ¢Õ∫§ÿ≥ §≥–‡¿ —™»“ μ√å·≈– of content uniformity and weight variation test-the state
§≥–°“√·æ∑¬å·ºπμ–«—πÕÕ° ¡À“«‘∑¬“≈—¬√—ß ‘μ of commercial tablets and capsules in Japan. Chem Pharm
Bull. 2001;49(11):1412-9.
∑’Ë π—∫ πÿπ‡§√◊ËÕß¡◊Õ·≈–«— ¥ÿÕÿª°√≥å μ≈Õ¥®πß∫
13. Khokra SL, Parashar B, Dhamija HK, Purohit R, Chandel
ª√–¡“≥°“√«‘®—¬ A. Formulation development and evaluation of chewable
tablet of albendazole by different techniques. Int J Pharm
Pharm Sci. 2012;4(1):461-4.
‡Õ° “√Õâ“ßÕ‘ß
14. Musa H, Sule YZ, Gwarzo MS. Assessment of
1. Ansari SH, Islam F, Sameem M. Influence of physicochemical properties of metronidazole tablets
nanotechnology on herbal drugs: A review. J Adv Pharm marketed in Zaria, Nigeria. Int J Pharm Pharm Sci.
Technol Res. 2012;3(3):142-6. 2011;3(3):27-9.
2. Kiyohara H, Matsumoto T, Yamada H. Combination effects 15. Patel SS, Patel NM. Development of directly compressible
of herbs in a multi-herbal formula: expression of Juzen- co-processed excipient for dispersible tablets using 32
taiho-toûs immuno-modulatory activity on the intestinal full factorial designs. Int J Pharm Pharm Sci. 2009;1(1):125-
immune system. eCAM. 2004;1(1):83-91. 48.
3. Lee HJ, Lee EO, Rhee YH, Ahn KS, Li GX, Jiang C, et al. 16. Patel V. Formulation and evaluation of delayed release
An oriental herbal cocktail, ka-mi-kae-kyuk-tang, exerts anti- pantoprazole tablets. Asian J Res Pharm Sci. 2013;3(2):95-
cancer activities by targeting angiogenesis, apoptosis and 106.
metastasis. Carcinogenesis 2006;27(12):2455-63. 17. Nazmi M, Islam SMA, Bhuiyan MA, Reza MS. Effect of
4. ∫ÿ…∫“ ª√–¿“ æß»å, Õÿ∑—¬ ‰™¬°≈“ß, »‘√‘¡“≈“ ÿ«√√≥ superdisintegrants and their mode of incorporation on
‚¿§‘π (∫√√≥“∏‘°“√). ·æ∑¬å»“ μ√å ߇§√“–Àå: ¿Ÿ¡‘ disintegration time and release profile of carbamazepine
ªí≠≠“∑“ß°“√·æ∑¬å·≈–¡√¥°∑“ß«√√≥°√√¡¢Õß™“μ‘. from immediate release tablet. J Appl Pharm Sci. 2013;
æ‘¡æå§√—Èß∑’Ë 3. °√ÿ߇∑æœ: ”π—°ß“π à߇ √‘¡ «— ¥‘°“√ 3(5):80-4.
·≈– «— ¥‘¿“æ§√Ÿ·≈–∫ÿ§≈“°√∑“ß°“√»÷°…“°√ÿ߇∑æ- 18. Kucinskate A, Sawicki W, Briedis V, Sznitowska M. Fast
¡À“π§√; 2551. Àπâ“ 545-7. disintegrating tablets containing Rhodiola rosea L. extract.
5. ‰ « ÿπ∑√. μ”√“¬“ÀÕ¡. °√ÿ߇∑æœ: ‡Õ¡’ˇ∑√¥¥‘Èß; 2544. Acta Pol Pharm Drug Res. 2007;64(1):63-7.
Àπâ“ 13-6. 19. Parkash V, Maan S, Deepika, Yadav SK, Hemlata, Jogpal
6. Summers M. Powders and granules. In: Aulton ME, editor. V. Fast disintegrating tablets: Opportunity in drug delivery
Pharmaceutics the Science of Dosage Form Design. Spain: system. J Adv Pharm Technol Res. 2011;2(4):223-35.
Churchill Livingstone; 2002. p. 361-3. 20. Patil C, Das S. Effect of various superdisintegrants on the
7. Dokala GK. Direct compression-An overview. Int J Res drug release profile and disintegration time of lamotrigine
Pharm Biomed Sci. 2013;4(1):155-8. orally disintegrating tablets. Afr J Pharm Pharmacol.
8. The United States Pharmacopeial Convention. The United 2011;5(1):76-82.